Overview of pharma outsourcing services provided by contract research, development, and manufacturing (CRO-CDMO) organizations for small molecules and biologics businesses.
We will talk about the value addition that CROs and CDMOs bring into the drug development lifecycle in today’s fast-changing world with scalable and sustainable solutions. The CRO/CDMO market is currently growing globally at a tremendous pace with India and China at the center of it. While the CROs and CDMOs are increasingly becoming an integral part of the pharma and biotech industry, it is also important to know how Syngene has transformed its supply chain to ensure business continuity amidst disruptions, enable seamless operations for the business and extract value from its supplier ecosystem.